|
Schlusskurs
Nasdaq
|
||
| - USD | - |
|
| 22.08.16 | Pfizer bietet Milliarden für Biopharmaspezialisten Medivation | DP |
| 22.08.16 | Amgen : Pfizer kauft US-Krebsspezialisten Medivation für 14 Milliarden Dollar | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.21% | -4.43% | -12.27% | +16.53% | +62.57% | +44.40% | +74.13% | +4.36% | - | 66.34 Mrd. | |
| -0.22% | +6.53% | +13.63% | +10.57% | +15.95% | +11.68% | +87.32% | -16.96% | +237.26% | 52.92 Mrd. | |
| +0.82% | +5.41% | -9.38% | +3.47% | +9.74% | +8.05% | +73.53% | +209.44% | +5’258.31% | 54.82 Mrd. | |
| +3.28% | +5.58% | +2.50% | +37.20% | +22.72% | +26.51% | +50.05% | +8.55% | +273.72% | 44.09 Mrd. | |
| +0.51% | +9.95% | +5.69% | +21.27% | +27.20% | +22.40% | +133.92% | +2.98% | +1’066.50% | 43.72 Mrd. | |
| -1.15% | +0.39% | +0.79% | +6.00% | +143.92% | +263.21% | +594.60% | +610.87% | - | 42.13 Mrd. | |
| +0.10% | +9.90% | +8.93% | +15.15% | +14.63% | +16.11% | +59.33% | +10.50% | +165.28% | 33.96 Mrd. | |
| -1.30% | -0.68% | -6.79% | +27.25% | +57.12% | +37.15% | +7.16% | -56.32% | - | 26.17 Mrd. | |
| +0.69% | +5.60% | +15.93% | +41.43% | +29.26% | +36.60% | +26.94% | -11.07% | +130.84% | 23.37 Mrd. | |
| +0.13% | +2.97% | -6.85% | -1.13% | -4.11% | -14.59% | +0.42% | -68.12% | - | 22.9 Mrd. | |
| -1.70% | -3.83% | -22.28% | -13.42% | -45.97% | -43.11% | +274.96% | +241.72% | +569.80% | 20.89 Mrd. | |
| +6.43% | +7.44% | +6.13% | +24.60% | +17.95% | +21.41% | +188.98% | +256.11% | +2’016.55% | 17.37 Mrd. | |
| +0.30% | +5.89% | +12.86% | +15.07% | +47.34% | +78.74% | +205.92% | +202.77% | +458.65% | 15.95 Mrd. | |
| +2.41% | +3.90% | +3.64% | +16.14% | +29.65% | +29.44% | +75.91% | -22.21% | +90.04% | 15.41 Mrd. | |
| +1.95% | +5.24% | +0.55% | -6.39% | - | - | - | - | - | 15.39 Mrd. | |
| +1.73% | -1.26% | +2.17% | 0.00% | +177.32% | +151.62% | +366.59% | +1’443.68% | +750.84% | 14.65 Mrd. | |
| +9.33% | +14.20% | +23.60% | +57.19% | +72.88% | +83.19% | +86.00% | -17.34% | +319.91% | 15.06 Mrd. | |
| +1.11% | +8.23% | -4.52% | -7.49% | +20.65% | +0.47% | +552.24% | - | - | 14.25 Mrd. | |
| +6.35% | +9.63% | +9.26% | +11.18% | +1.66% | -4.14% | -18.29% | -33.15% | +119.13% | 13.44 Mrd. | |
| Durchschnitt | +1.61% | +4.48% | +2.29% | +14.45% | +38.92% | +42.73% | +157.76% | +162.69% | +881.29% | 27.64 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.98% | +4.35% | +0.88% | +14.98% | +38.96% | +44.45% | +143.82% | +128.10% | +1’206.70% |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
